Publications

Export 143 results:
Sort by: [ Author (Desc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B [C] D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
C
Czarnecki A, Welsh RC, Yan RT, DeYoung PJ, Gallo R, Rose B, et al. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). Can J Cardiol. 2012;28(1):40-7. Abstract
Czarnecki A, Welsh RC, Yan RT, DeYoung PJ, Gallo R, Rose B, et al. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). Can J Cardiol. 2012;28(1):40-7. Abstract
Cudmore MJ, Ramma W, Cai M, Fujisawa T, Ahmad S, Al-Ani B, et al. Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta. American journal of obstetrics and gynecology. 2011. Abstract
Cudmore MJ, Ahmad S, Sissaoui S, Ramma W, Ma B, Fujisawa T, et al. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. European heart journal. 2011. Abstract
Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007;115(13):1789-97. Abstract
Cudmore MJ, Hewett PW, Ahmad S, Wang K-, Cai M, Al-Ani B, et al. The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis. Nat Commun. 2012;3:972. Abstract
Cubbon RM, Gale CP, Kearney LC, Schechter CB, Brooksby PW, Nolan J, et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail. 2011;4(4):396-403. Abstract
Crüts B, van Etten L, Törnqvist H, Blomberg A, Sandström T, Mills NL, et al. Exposure to diesel exhaust induces changes in EEG in human volunteers. Particle and fibre toxicology. 2008;5:4. Abstract
Cruden NL, Harding SA, Flapan AD, Graham C, Wild SH, Slack R, et al. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv. 2010;3(3):236-42. Abstract
Cruden NL, Lang NN, Macgillivray TJ, Uren NG, Fox KA, Newby DE. Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb. Heart and vessels. 2011. Abstract
Cruden NL, Tse GH, Fox KA, Ludlam CA, Megson I, Newby DE. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure. Arterioscler Thromb Vasc Biol. 2005;25(4):772-7. Abstract
Cruden NL, Harding SA, Newby DE. Coronary stent thrombosis in the perioperative period. BMJ. 2008;337:a2074.
Cruden NL, Teh CH, Starkey IR, Newby DE. Reduced vascular complications and length of stay with transradial rescue angioplasty for acute myocardial infarction. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2007;70:670-5. Abstract
Cruden NL, Fox KA, Ludlam CA, Johnston NR, Newby DE. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition. Hypertension. 2004;44(6):913-8. Abstract
Cruden NL, Lawes L, Masson P, Robinson SD, Ludlam CA, Newby DE. Inhibition of thrombin activatable fibrinolysis inhibitor augments fibrinolysis in human whole blood. J Thromb Haemost. 2005;3(10):2351-3.
Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Arterioscler Thromb Vasc Biol. 2004;24(6):1043-8. Abstract
Cruden NL, Graham C, Harding SA, Ludlam CA, Fox KA, Newby DE. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. Thromb Res. 2006;118(2):189-97. Abstract
Cruden NL, Newby DE, Webb DJ. Salmeterol for the prevention of high-altitude pulmonary edema. The New England journal of medicine. 2002;347:1282-5; author reply 1282-5.
Cruden NL, Morch K, Wong DR, Klinke PW, Ofiesh J, Hilton DJ. Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting. Am Heart J. 2011;161(2):404-10. Abstract
Crossman DC, Morton AC, Gunn JP, Greenwood JP, Hall AS, Fox KA, et al. Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study). Trials. 2008;9:8. Abstract
Cross MD, Mills NL, Al-Abri M, Riha R, Vennelle M, Mackay TW, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax. 2008;63:578-83. Abstract
Crockett TR, Gray GA, Kane KA, Wainwright CL. Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats. J Cardiovasc Pharmacol. 2004;44(2):148-54. Abstract
Crispi F, Hernandez-Andrade E, Pelsers MM, Plasencia W, Benavides-Serralde JA, Eixarch E, et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol. 2008;199(3):254.e1-8. Abstract
Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, Le Noble F, et al. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation. 2010;121(22):2427-36. Abstract
Crisan M, Chen C-, Corselli M, Andriolo G, Lazzari L, Péault B. Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci. 2009;1176:118-23. Abstract